Reduced Uptake of FDOPA PET in End-Stage Liver Disease With Elevated Manganese Levels

Archives of Neurology
doi 10.1001/archneurol.2011.771
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Is IDH Mutation Status Associated With 18f-FDopa PET Uptake?

Annals of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2020English

Scurvy in the Context of End-Stage Liver Disease

Canadian Journal of General Internal Medicine
2016English

Interleukin 6 Predicts Mortality in Patients With End-Stage Liver Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Cellular Senescence in Livers From Children With End Stage Liver Disease

PLoS ONE
Multidisciplinary
2010English

Role of Nutrition in Liver Transplantation for End-Stage Chronic Liver Disease

Nutrition Reviews
MedicineNutritionDietetics
2008English

Peritoneal Dialysis in End-Stage Renal Disease Patients With Preexisting Chronic Liver Disease and Ascites

American Journal of Medicine
Medicine
1992English

Osseous and Nonosseous Bone Scan Findings in Liver Transplant Candidates With End-Stage Chronic Liver Disease

Molecular Imaging and Radionuclide Therapy
Nuclear MedicineRadiologyImaging
2013English

Clinician Assessments of Health Status Predict Mortality in Patients With End-Stage Liver Disease Awaiting Liver Transplantation

Liver International
Hepatology
2015English

Survival Prediction Among Patients With Non-Cancer-Related End-Stage Liver Disease

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy